FourWorld Capital Management’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.79M | Hold |
1,226,710
| – | – | 2.55% | 6 |
|
|
2025
Q1 | $4.28M | Hold |
1,226,710
| – | – | 2.75% | 5 |
|
|
2024
Q4 | $4.01M | Sell |
1,226,710
-1,745,817
| -59% | -$5.71M | 2.08% | 6 |
|
|
2024
Q3 | $11.4M | Hold |
2,972,527
| – | – | 6.59% | 3 |
|
|
2024
Q2 | $9.19M | Sell |
2,972,527
-28,000
| -0.9% | -$86.5K | 5.5% | 4 |
|
|
2024
Q1 | $7.74M | Buy |
3,000,527
+1,909,676
| +175% | +$4.93M | 4.94% | 5 |
|
|
2023
Q4 | $2.73M | Sell |
1,090,851
-251,056
| -19% | -$628K | 1.47% | 7 |
|
|
2023
Q3 | $2.72M | Hold |
1,341,907
| – | – | 0.51% | 12 |
|
|
2023
Q2 | $3.09M | Sell |
1,341,907
-658,183
| -33% | -$1.51M | 0.51% | 9 |
|
|
2023
Q1 | $6.06M | Hold |
2,000,090
| – | – | 1.39% | 7 |
|
|
2022
Q4 | $4.66M | Hold |
2,000,090
| – | – | 6.41% | 5 |
|
|
2022
Q3 | $3.82M | Buy |
2,000,090
+199,090
| +11% | +$380K | 6.05% | 4 |
|
|
2022
Q2 | $4.88M | Buy |
1,801,000
+253,261
| +16% | +$686K | 7.77% | 4 |
|
|
2022
Q1 | $4.61M | Buy |
+1,547,739
| New | +$4.61M | 2.86% | 5 |
|